Literature DB >> 29076591

Long-Term Magnetization Transfer Ratio Evolution in Multiple Sclerosis White Matter Lesions.

Yufan Zheng1,2, Jar-Chi Lee3, Richard Rudick4, Elizabeth Fisher1.   

Abstract

BACKGROUND AND
PURPOSE: Magnetization transfer ratio (MTR), a magnetic resonance imaging technique used to assess tissue integrity, correlates with demyelination and axonal loss in multiple sclerosis (MS) lesions. In acute white matter lesions, short-term MTR changes mainly reflect demyelination and remyelination, in addition to edema and axonal and glial changes. Long-term MTR changes in MS lesions have not been studied extensively.
METHODS: A new quantitative image analysis method was developed to measure long-term MTR changes in MS lesions. The method was applied to a group of 59 patients and 14 healthy control subjects followed for 4 years. MTR changes in white matter lesions were analyzed, where lesion voxels were classified into six categories based on starting MTR and change over time. For each patient, the proportion of lesion voxels in each MTR-change category was calculated. Correlations between long-term MTR evolution, disability progression, and brain atrophy were investigated.
RESULTS: The proportion of lesion voxels in the high stable category correlated with less atrophy progression, while the proportion with low and increasing MTR correlated with increased atrophy. The proportion of lesion voxels in the high and stable MTR lesion category was significantly different between MS disease subgroups. The group with disability progression had a higher proportion of lesion voxels with low and increasing MTR.
CONCLUSIONS: These results suggest that long-term changes in MTR in white matter lesions can be used to distinguish lesion subtypes associated with MS disease progression and improve understanding of the temporal evolution of MS pathology.
Copyright © 2017 by the American Society of Neuroimaging.

Entities:  

Keywords:  Multiple sclerosis; long-term lesion evolution; magnetization transfer ratio

Mesh:

Year:  2017        PMID: 29076591     DOI: 10.1111/jon.12480

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  7 in total

1.  MRI biomarkers of disease progression in multiple sclerosis: old dog, new tricks?

Authors:  Yael Barnett; Justin Y Garber; Michael H Barnett
Journal:  Quant Imaging Med Surg       Date:  2020-02

2.  Selective Inversion Recovery Quantitative Magnetization Transfer Brain MRI at 7T: Clinical and Postmortem Validation in Multiple Sclerosis.

Authors:  Francesca Bagnato; Simon Hametner; Giulia Franco; Siddharama Pawate; Subramaniam Sriram; Hans Lassmann; John Gore; Seth E Smith; Richard Dortch
Journal:  J Neuroimaging       Date:  2018-04-19       Impact factor: 2.486

Review 3.  Current and Future Biomarkers in Multiple Sclerosis.

Authors:  Jennifer Yang; Maysa Hamade; Qi Wu; Qin Wang; Robert Axtell; Shailendra Giri; Yang Mao-Draayer
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

Review 4.  Quantitative magnetization transfer imaging in relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.

Authors:  Elizabeth N York; Michael J Thrippleton; Rozanna Meijboom; David P J Hunt; Adam D Waldman
Journal:  Brain Commun       Date:  2022-04-04

5.  Magnetization Transfer Imaging Predicts Porcine Kidney Recovery After Revascularization of Renal Artery Stenosis.

Authors:  Mohsen Afarideh; Kai Jiang; Christopher M Ferguson; John R Woollard; James F Glockner; Lilach O Lerman
Journal:  Invest Radiol       Date:  2021-02-01       Impact factor: 10.065

6.  Kinetics of myelin breakdown products: A labeling study in patients with progressive multiple sclerosis.

Authors:  Kawita M S Kanhai; Sebastiaan C Goulooze; Jeroen van der Grond; Amy C Harms; Thomas Hankemeier; Ajay Verma; Gersham Dent; Juan Chavez; Henri Meijering; Geert Jan Groeneveld
Journal:  Clin Transl Sci       Date:  2021-11-19       Impact factor: 4.689

7.  A Comparison of Magnetic Resonance Imaging Methods to Assess Multiple Sclerosis Lesions: Implications for Patient Characterization and Clinical Trial Design.

Authors:  Ewart Mark Haacke; Evanthia Bernitsas; Karthik Subramanian; David Utriainen; Vinay Kumar Palutla; Kiran Yerramsetty; Prashanth Kumar; Sean K Sethi; Yongsheng Chen; Zahid Latif; Pavan Jella; Sara Gharabaghi; Ying Wang; Xiaomeng Zhang; Robert A Comley; John Beaver; Yanping Luo
Journal:  Diagnostics (Basel)       Date:  2021-12-30
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.